• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE EXCLUDERAAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE EXCLUDERAAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number PLA320400
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Aneurysm (1708)
Date of Event 09/16/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Patient comorbidities: hypertension and pvd.The gore® excluder® aaa endoprosthesis instructions for use (ifu) states that adverse events that may occur and/or require intervention include, but are not limited to endoleak.
 
Event or Problem Description
On (b)(6) 2019, the patient was implanted with gore® excluder® aaa endoprostheses to treat an abdominal aortic aneurysm.It was reported that the patient had a possible proximal type i or type ii endoleak (date and modality of images is unknown) and the physician wanted to reintervene.There is aneurysm sac enlargement reported (amount is unknown).The physician determined that it was a proximal type i endoleak and during reintervention placed 12 aptus screws in the area of the proximal neck of the initial graft (pla320400/18785494).In addition, the physician placed a palmaz stent (p4010) in the area as well to treat the endoleak.Upon completion of this intervention, the endoleak was successfully treated and the patient is reported to be doing well.
 
Additional Manufacturer Narrative
Addition h6: code 213-a review of the manufacturing records for the device verified that the lot met all pre-release specifications.
 
Additional Manufacturer Narrative
Addition g5.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE EXCLUDERAAA ENDOPROSTHESIS
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key10691998
Report Number3013164176-2020-01057
Device Sequence Number17120433
Product Code MIH
UDI-Device Identifier00733132618804
UDI-Public00733132618804
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
P020004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 01/15/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date11/01/2021
Device Model NumberPLA320400
Device Catalogue NumberPLA320400
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 10/16/2020
Supplement Date Received by Manufacturer10/16/2020
10/16/2020
Initial Report FDA Received Date10/16/2020
Supplement Report FDA Received Date12/29/2020
01/15/2021
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization;
Patient Age88 YR
Patient Weight80
-
-